Benefit of living donor liver transplantation: Who and when?

Hepatology

Volumn 54, Issue 4, 2011, Pages 1125-1126

  Heimbach, Julie K ^a   Wiesner, Russell H ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ASCITES; BLOOD GROUP; BRAIN DISEASE; CHOLESTASIS; CLINICAL EVALUATION; DONOR SELECTION; FOLLOW UP; HEPATITIS C; HOSPITAL POLICY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; NOTE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PRURITUS; RACE DIFFERENCE; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; WAITING LISTS;

EID: 80053326672     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24578     Document Type: Note

References (6)

1. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RSJr., Baker TB, et al. Liver transplant recipient survival benefit with living donation in the MELD allocation era. HEPATOLOGY 2011;54:1313.
2. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313.
3. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-425.
4. Asrani SK, Young-Suk L, Therneau T, et al. Donor race does not predict graft failure after liver transplantation. Gastroenterology 2010; 138: 2341-2347.
5. Volk ML, Reichert HA, Lok AS, Hayward RA. Variation of organ quality between liver transplant centers. Am J Transplant 2011; 11: 958-964.
6. Yeh H, Smoot E, Schoenfeld DA, Markmann JF. Geographic inequity in access to livers for transplantation. Transplantation 2011; 91: 479-486.